Parkinson's Disease Drugs, Oral & Topical

• Parkinson's Disease - Feb 06, 2025
• Parkinson's Disease - Oct 01, 2020
• Anti-Parkinson's Agents - Mar 22, 2018
• Anti-Parkinson's Agents - Jul 28, 2016
• Anti-Parkinson's Agents - Sep 23, 2014
• Parkinsons Disease: Abbreviated Class Update - Nov 21, 2013
• Abbreviated Class Update: Parkinson's Drugs - Sep 26, 2013
• Class Scan: Anti-Parkinson's Agents - Feb 23, 2012

Y = preferred
N = non-preferred. Non-preferred drugs listed as N but without clinical drug use criteria are subject to the Non-Preferred Drugs in Select PDL Classes prior authorization criteria. New drugs will be listed as N until reviewed by the P&T Committee and are subject to the New Drug Policy.
V = voluntary non-preferred. Non-preferred mental health drugs are listed as V and prior authorization is not required.
Null (i.e. blank) = indicates the class or specific drug has not been reviewed for PDL placement.